1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Breakthrough Therapy Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1.2.2 Oncology 1.2.3 Anti-Viral 1.2.4 Neurology 1.2.5 Others 1.3 Market by Application 1.3.1 Global Breakthrough Therapy Drugs Market Growth by Application: 2018 VS 2022 VS 2029 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Ambulatory Services 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Breakthrough Therapy Drugs Market Perspective (2018-2029) 2.2 Breakthrough Therapy Drugs Growth Trends by Region 2.2.1 Global Breakthrough Therapy Drugs Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Breakthrough Therapy Drugs Historic Market Size by Region (2018-2023) 2.2.3 Breakthrough Therapy Drugs Forecasted Market Size by Region (2024-2029) 2.3 Breakthrough Therapy Drugs Market Dynamics 2.3.1 Breakthrough Therapy Drugs Industry Trends 2.3.2 Breakthrough Therapy Drugs Market Drivers 2.3.3 Breakthrough Therapy Drugs Market Challenges 2.3.4 Breakthrough Therapy Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Breakthrough Therapy Drugs Players by Revenue 3.1.1 Global Top Breakthrough Therapy Drugs Players by Revenue (2018-2023) 3.1.2 Global Breakthrough Therapy Drugs Revenue Market Share by Players (2018-2023) 3.2 Global Breakthrough Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Breakthrough Therapy Drugs Revenue 3.4 Global Breakthrough Therapy Drugs Market Concentration Ratio 3.4.1 Global Breakthrough Therapy Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Breakthrough Therapy Drugs Revenue in 2022 3.5 Breakthrough Therapy Drugs Key Players Head office and Area Served 3.6 Key Players Breakthrough Therapy Drugs Product Solution and Service 3.7 Date of Enter into Breakthrough Therapy Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Breakthrough Therapy Drugs Breakdown Data by Type 4.1 Global Breakthrough Therapy Drugs Historic Market Size by Type (2018-2023) 4.2 Global Breakthrough Therapy Drugs Forecasted Market Size by Type (2024-2029) 5 Breakthrough Therapy Drugs Breakdown Data by Application 5.1 Global Breakthrough Therapy Drugs Historic Market Size by Application (2018-2023) 5.2 Global Breakthrough Therapy Drugs Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Breakthrough Therapy Drugs Market Size (2018-2029) 6.2 North America Breakthrough Therapy Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 6.3 North America Breakthrough Therapy Drugs Market Size by Country (2018-2023) 6.4 North America Breakthrough Therapy Drugs Market Size by Country (2024-2029) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Breakthrough Therapy Drugs Market Size (2018-2029) 7.2 Europe Breakthrough Therapy Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 Europe Breakthrough Therapy Drugs Market Size by Country (2018-2023) 7.4 Europe Breakthrough Therapy Drugs Market Size by Country (2024-2029) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Breakthrough Therapy Drugs Market Size (2018-2029) 8.2 Asia-Pacific Breakthrough Therapy Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029 8.3 Asia-Pacific Breakthrough Therapy Drugs Market Size by Region (2018-2023) 8.4 Asia-Pacific Breakthrough Therapy Drugs Market Size by Region (2024-2029) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Breakthrough Therapy Drugs Market Size (2018-2029) 9.2 Latin America Breakthrough Therapy Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Latin America Breakthrough Therapy Drugs Market Size by Country (2018-2023) 9.4 Latin America Breakthrough Therapy Drugs Market Size by Country (2024-2029) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Breakthrough Therapy Drugs Market Size (2018-2029) 10.2 Middle East & Africa Breakthrough Therapy Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Middle East & Africa Breakthrough Therapy Drugs Market Size by Country (2018-2023) 10.4 Middle East & Africa Breakthrough Therapy Drugs Market Size by Country (2024-2029) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 Merck 11.1.1 Merck Company Detail 11.1.2 Merck Business Overview 11.1.3 Merck Breakthrough Therapy Drugs Introduction 11.1.4 Merck Revenue in Breakthrough Therapy Drugs Business (2018-2023) 11.1.5 Merck Recent Development 11.2 Pfizer 11.2.1 Pfizer Company Detail 11.2.2 Pfizer Business Overview 11.2.3 Pfizer Breakthrough Therapy Drugs Introduction 11.2.4 Pfizer Revenue in Breakthrough Therapy Drugs Business (2018-2023) 11.2.5 Pfizer Recent Development 11.3 AbbVie 11.3.1 AbbVie Company Detail 11.3.2 AbbVie Business Overview 11.3.3 AbbVie Breakthrough Therapy Drugs Introduction 11.3.4 AbbVie Revenue in Breakthrough Therapy Drugs Business (2018-2023) 11.3.5 AbbVie Recent Development 11.4 Bristol-Myers Squibb Company 11.4.1 Bristol-Myers Squibb Company Company Detail 11.4.2 Bristol-Myers Squibb Company Business Overview 11.4.3 Bristol-Myers Squibb Company Breakthrough Therapy Drugs Introduction 11.4.4 Bristol-Myers Squibb Company Revenue in Breakthrough Therapy Drugs Business (2018-2023) 11.4.5 Bristol-Myers Squibb Company Recent Development 11.5 Genentech 11.5.1 Genentech Company Detail 11.5.2 Genentech Business Overview 11.5.3 Genentech Breakthrough Therapy Drugs Introduction 11.5.4 Genentech Revenue in Breakthrough Therapy Drugs Business (2018-2023) 11.5.5 Genentech Recent Development 11.6 Gilead 11.6.1 Gilead Company Detail 11.6.2 Gilead Business Overview 11.6.3 Gilead Breakthrough Therapy Drugs Introduction 11.6.4 Gilead Revenue in Breakthrough Therapy Drugs Business (2018-2023) 11.6.5 Gilead Recent Development 11.7 Novartis 11.7.1 Novartis Company Detail 11.7.2 Novartis Business Overview 11.7.3 Novartis Breakthrough Therapy Drugs Introduction 11.7.4 Novartis Revenue in Breakthrough Therapy Drugs Business (2018-2023) 11.7.5 Novartis Recent Development 11.8 Vertex Pharmaceuticals Incorporated 11.8.1 Vertex Pharmaceuticals Incorporated Company Detail 11.8.2 Vertex Pharmaceuticals Incorporated Business Overview 11.8.3 Vertex Pharmaceuticals Incorporated Breakthrough Therapy Drugs Introduction 11.8.4 Vertex Pharmaceuticals Incorporated Revenue in Breakthrough Therapy Drugs Business (2018-2023) 11.8.5 Vertex Pharmaceuticals Incorporated Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Breakthrough Therapy Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029 Table 2. Key Players of Oncology Table 3. Key Players of Anti-Viral Table 4. Key Players of Neurology Table 5. Key Players of Others Table 6. Global Breakthrough Therapy Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029 Table 7. Global Breakthrough Therapy Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 8. Global Breakthrough Therapy Drugs Market Size by Region (2018-2023) & (US$ Million) Table 9. Global Breakthrough Therapy Drugs Market Share by Region (2018-2023) Table 10. Global Breakthrough Therapy Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million) Table 11. Global Breakthrough Therapy Drugs Market Share by Region (2024-2029) Table 12. Breakthrough Therapy Drugs Market Trends Table 13. Breakthrough Therapy Drugs Market Drivers Table 14. Breakthrough Therapy Drugs Market Challenges Table 15. Breakthrough Therapy Drugs Market Restraints Table 16. Global Breakthrough Therapy Drugs Revenue by Players (2018-2023) & (US$ Million) Table 17. Global Breakthrough Therapy Drugs Market Share by Players (2018-2023) Table 18. Global Top Breakthrough Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breakthrough Therapy Drugs as of 2022) Table 19. Ranking of Global Top Breakthrough Therapy Drugs Companies by Revenue (US$ Million) in 2022 Table 20. Global 5 Largest Players Market Share by Breakthrough Therapy Drugs Revenue (CR5 and HHI) & (2018-2023) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Breakthrough Therapy Drugs Product Solution and Service Table 23. Date of Enter into Breakthrough Therapy Drugs Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Breakthrough Therapy Drugs Market Size by Type (2018-2023) & (US$ Million) Table 26. Global Breakthrough Therapy Drugs Revenue Market Share by Type (2018-2023) Table 27. Global Breakthrough Therapy Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million) Table 28. Global Breakthrough Therapy Drugs Revenue Market Share by Type (2024-2029) Table 29. Global Breakthrough Therapy Drugs Market Size by Application (2018-2023) & (US$ Million) Table 30. Global Breakthrough Therapy Drugs Revenue Market Share by Application (2018-2023) Table 31. Global Breakthrough Therapy Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million) Table 32. Global Breakthrough Therapy Drugs Revenue Market Share by Application (2024-2029) Table 33. North America Breakthrough Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 34. North America Breakthrough Therapy Drugs Market Size by Country (2018-2023) & (US$ Million) Table 35. North America Breakthrough Therapy Drugs Market Size by Country (2024-2029) & (US$ Million) Table 36. Europe Breakthrough Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 37. Europe Breakthrough Therapy Drugs Market Size by Country (2018-2023) & (US$ Million) Table 38. Europe Breakthrough Therapy Drugs Market Size by Country (2024-2029) & (US$ Million) Table 39. Asia-Pacific Breakthrough Therapy Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029 Table 40. Asia-Pacific Breakthrough Therapy Drugs Market Size by Region (2018-2023) & (US$ Million) Table 41. Asia-Pacific Breakthrough Therapy Drugs Market Size by Region (2024-2029) & (US$ Million) Table 42. Latin America Breakthrough Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 43. Latin America Breakthrough Therapy Drugs Market Size by Country (2018-2023) & (US$ Million) Table 44. Latin America Breakthrough Therapy Drugs Market Size by Country (2024-2029) & (US$ Million) Table 45. Middle East & Africa Breakthrough Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 46. Middle East & Africa Breakthrough Therapy Drugs Market Size by Country (2018-2023) & (US$ Million) Table 47. Middle East & Africa Breakthrough Therapy Drugs Market Size by Country (2024-2029) & (US$ Million) Table 48. Merck Company Detail Table 49. Merck Business Overview Table 50. Merck Breakthrough Therapy Drugs Product Table 51. Merck Revenue in Breakthrough Therapy Drugs Business (2018-2023) & (US$ Million) Table 52. Merck Recent Development Table 53. Pfizer Company Detail Table 54. Pfizer Business Overview Table 55. Pfizer Breakthrough Therapy Drugs Product Table 56. Pfizer Revenue in Breakthrough Therapy Drugs Business (2018-2023) & (US$ Million) Table 57. Pfizer Recent Development Table 58. AbbVie Company Detail Table 59. AbbVie Business Overview Table 60. AbbVie Breakthrough Therapy Drugs Product Table 61. AbbVie Revenue in Breakthrough Therapy Drugs Business (2018-2023) & (US$ Million) Table 62. AbbVie Recent Development Table 63. Bristol-Myers Squibb Company Company Detail Table 64. Bristol-Myers Squibb Company Business Overview Table 65. Bristol-Myers Squibb Company Breakthrough Therapy Drugs Product Table 66. Bristol-Myers Squibb Company Revenue in Breakthrough Therapy Drugs Business (2018-2023) & (US$ Million) Table 67. Bristol-Myers Squibb Company Recent Development Table 68. Genentech Company Detail Table 69. Genentech Business Overview Table 70. Genentech Breakthrough Therapy Drugs Product Table 71. Genentech Revenue in Breakthrough Therapy Drugs Business (2018-2023) & (US$ Million) Table 72. Genentech Recent Development Table 73. Gilead Company Detail Table 74. Gilead Business Overview Table 75. Gilead Breakthrough Therapy Drugs Product Table 76. Gilead Revenue in Breakthrough Therapy Drugs Business (2018-2023) & (US$ Million) Table 77. Gilead Recent Development Table 78. Novartis Company Detail Table 79. Novartis Business Overview Table 80. Novartis Breakthrough Therapy Drugs Product Table 81. Novartis Revenue in Breakthrough Therapy Drugs Business (2018-2023) & (US$ Million) Table 82. Novartis Recent Development Table 83. Vertex Pharmaceuticals Incorporated Company Detail Table 84. Vertex Pharmaceuticals Incorporated Business Overview Table 85. Vertex Pharmaceuticals Incorporated Breakthrough Therapy Drugs Product Table 86. Vertex Pharmaceuticals Incorporated Revenue in Breakthrough Therapy Drugs Business (2018-2023) & (US$ Million) Table 87. Vertex Pharmaceuticals Incorporated Recent Development Table 88. Research Programs/Design for This Report Table 89. Key Data Information from Secondary Sources Table 90. Key Data Information from Primary Sources List of Figures Figure 1. Global Breakthrough Therapy Drugs Market Size Comparison by Type (2023-2029) & (US$ Million) Figure 2. Global Breakthrough Therapy Drugs Market Share by Type: 2022 VS 2029 Figure 3. Oncology Features Figure 4. Anti-Viral Features Figure 5. Neurology Features Figure 6. Others Features Figure 7. Global Breakthrough Therapy Drugs Market Size Comparison by Application (2023-2029) & (US$ Million) Figure 8. Global Breakthrough Therapy Drugs Market Share by Application: 2022 VS 2029 Figure 9. Hospitals Case Studies Figure 10. Clinics Case Studies Figure 11. Ambulatory Services Case Studies Figure 12. Breakthrough Therapy Drugs Report Years Considered Figure 13. Global Breakthrough Therapy Drugs Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 14. Global Breakthrough Therapy Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 15. Global Breakthrough Therapy Drugs Market Share by Region: 2022 VS 2029 Figure 16. Global Breakthrough Therapy Drugs Market Share by Players in 2022 Figure 17. Global Top Breakthrough Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breakthrough Therapy Drugs as of 2022) Figure 18. The Top 10 and 5 Players Market Share by Breakthrough Therapy Drugs Revenue in 2022 Figure 19. North America Breakthrough Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 20. North America Breakthrough Therapy Drugs Market Share by Country (2018-2029) Figure 21. United States Breakthrough Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 22. Canada Breakthrough Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 23. Europe Breakthrough Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 24. Europe Breakthrough Therapy Drugs Market Share by Country (2018-2029) Figure 25. Germany Breakthrough Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 26. France Breakthrough Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 27. U.K. Breakthrough Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 28. Italy Breakthrough Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. Russia Breakthrough Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. Nordic Countries Breakthrough Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 31. Asia-Pacific Breakthrough Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 32. Asia-Pacific Breakthrough Therapy Drugs Market Share by Region (2018-2029) Figure 33. China Breakthrough Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 34. Japan Breakthrough Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 35. South Korea Breakthrough Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 36. Southeast Asia Breakthrough Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 37. India Breakthrough Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 38. Australia Breakthrough Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 39. Latin America Breakthrough Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 40. Latin America Breakthrough Therapy Drugs Market Share by Country (2018-2029) Figure 41. Mexico Breakthrough Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 42. Brazil Breakthrough Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 43. Middle East & Africa Breakthrough Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 44. Middle East & Africa Breakthrough Therapy Drugs Market Share by Country (2018-2029) Figure 45. Turkey Breakthrough Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 46. Saudi Arabia Breakthrough Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 47. Merck Revenue Growth Rate in Breakthrough Therapy Drugs Business (2018-2023) Figure 48. Pfizer Revenue Growth Rate in Breakthrough Therapy Drugs Business (2018-2023) Figure 49. AbbVie Revenue Growth Rate in Breakthrough Therapy Drugs Business (2018-2023) Figure 50. Bristol-Myers Squibb Company Revenue Growth Rate in Breakthrough Therapy Drugs Business (2018-2023) Figure 51. Genentech Revenue Growth Rate in Breakthrough Therapy Drugs Business (2018-2023) Figure 52. Gilead Revenue Growth Rate in Breakthrough Therapy Drugs Business (2018-2023) Figure 53. Novartis Revenue Growth Rate in Breakthrough Therapy Drugs Business (2018-2023) Figure 54. Vertex Pharmaceuticals Incorporated Revenue Growth Rate in Breakthrough Therapy Drugs Business (2018-2023) Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Merck Pfizer AbbVie Bristol-Myers Squibb Company Genentech Gilead Novartis Vertex Pharmaceuticals Incorporated